Schrödinger, Inc. is an international scientific software company specializing in developing computational tools and software for drug discovery and materials science. Their software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level, accelerating the design and development of new drugs and materials more efficiently, reducing time and cost.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

COM:SCHRODINGER

Schrödinger, Inc.

Last Close

19.17

21/11 16:28

Market Cap

1.50B

Beta: -

Volume Today

171.22K

Avg: -

market

industry

website

crunchbase

ipo date

peer of

invested in

competitor of

Metrics